SEM's $16.50 Take-Private Moment: Undervalued or Perfectly Timed?
Select MedicalSelect Medical(US:SEM) ZACKS·2026-03-04 15:06

Core Insights - Select Medical Holdings Corporation (SEM) plans to go private through an acquisition valued at $3.9 billion, led by Executive Chairman Robert Ortenzio and private equity firm Welsh, Carson, Anderson & Stowe, resulting in an 8.4% surge in stock price [1] Company Overview - Shareholders will receive $16.50 per share in cash, which is a 10% premium to the March 2, 2026 closing price and an 18% premium to the November 24, 2025 level, although it is below the average analyst target of $17.70 [2] - The current management is expected to remain in place post-acquisition, which is anticipated to be completed by mid-2026 [3] - As of the end of 2025, Select Medical operated in 39 states and the District of Columbia, focusing on critical illness recovery and rehabilitation services [3] - The company reported a fourth-quarter 2025 adjusted EPS of 16 cents, down 11.1% year over year, while net operating revenues increased by 6.4% to $1.4 billion [3] - Select Medical has a current market cap of $1.86 billion [3] Industry Context - The acquisition comes at a time when healthcare providers face reimbursement pressure and cost volatility, which may allow Select Medical's management to streamline operations and pursue long-term strategic goals outside the public market [4] - Peers like Universal Health Services, Inc. (UHS) and Tenet Healthcare Corporation (THC) are also navigating similar challenges, with UHS facing lower-than-expected admissions and higher operating costs, while THC benefited from stronger revenues but faced rising expenses [5][6] Financial Performance - Select Medical's shares have declined by 9.9% over the past year, underperforming the broader industry and the S&P 500 Index [7] - The Zacks Consensus Estimate for Select Medical's 2026 earnings suggests a 10.3% rise year over year, followed by a projected 17.9% growth in 2027 [10] - The company trades at a forward price-to-earnings ratio of 12.31X, which is higher than the industry average of 11.77X, and carries a Value Score of A [11][12]

Select Medical-SEM's $16.50 Take-Private Moment: Undervalued or Perfectly Timed? - Reportify